Oral microbiota in aging and diseases

Abstract

Human microbiomes are microbial populations that form a symbiotic relationship with humans. There are up to 1000 species on the surface of human skin and mucosal system, among which gut microbiota attracts the most interest. As the beginning of the digestive tract, oral cavity is also an important microbial habitat in the human body which is the first line of defense against pathogens entering the body. Many studies have revealed that oral microbial dysbiosis could not only contribute to oral diseases but also whole-body systemic diseases and health status. Oral microorganisms can enter the gastrointestinal tract with saliva and food, or enter the blood circulation through mouth breakage, thus causing systemic inflammation and aging-related diseases including some causal links to Alzheimer’s disease. A series of changes take place in oral microbial composition during development, with different age stages marked by different dominant microbial species. Despite a lack of comprehensive studies on aging oral microbiota, through systemic inflammation, oral pathogenic microbes are likely to contribute inflammatory aging. As inflammaging is a key signature and one of the causes for accelerated aging, improving the structure of oral microbiome may be not only a new strategy for disease prevention and treatment, but also for aging intervention.

Keywords

oral microbiome / aging / disease

References

[1] López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of aging: an expanding universe. Cell 2023; 186: 243- 78.

[2] Lakshminarayanan B, Stanton C, O’Toole PW, et al. Compositional dynamics of the human intestinal microbiota with aging: implications for health. J Nutr Health Aging 2014; 18: 773- 86.

[3] Biagi E, Franceschi C, Rampelli S, et al. Gut microbiota and extreme longevity. Curr Biol 2016; 26: 1480- 5.

[4] Konturek PC, Haziri D, Brzozowski T, et al. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J Physiol Pharmacol 2015; 66: 483- 91.

[5] Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly.Nature 2012; 488: 178- 84.

[6] Xu X, He J, Xue J, et al. Oral cavity contains distinct niches with dynamic microbial communities. Environ Microbiol 2015; 17: 699- 710.

[7] Lozupone CA, Li M, Campbell TB, et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 2013; 14: 329- 39.

[8] Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014; 513: 59- 64.

[9] Gevers D, Kugathasan S, Denson LA, et al. The treatmentnaive microbiome in new-onset Crohn’s disease. Cell Host Microbe 2014; 15: 382- 92.

[10] Yang Y, Weng W, Peng J, et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor−κB, and Up-regulating expression of MicroRNA-21. Gastroenterology 2017; 152: 851- 66.e24.

[11] Bashir A, Miskeen AY, Bhat A, et al. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis. Eur J Cancer Prev 2015; 24: 373- 85.

[12] Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 2015; 42: 344- 55.

[13] Bashir A, Miskeen AY, Hazari YM, et al. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut. Tumour Biol 2016; 37: 2805- 10.

[14] Rogers MB, Brower-Sinning R, Firek B, et al. Acute appendicitis in children is associated with a local expansion of fusobacteria. Clin Infect Dis 2016; 63: 71- 8.

[15] Guinane CM, Tadrous A, Fouhy F, et al. Microbial composition of human appendices from patients following appendectomy. mBio 2013; 4: e00366- 12.

[16] Singhal S, Dian D, Keshavarzian A, et al. The role of oral hygiene in inflammatory bowel disease. Dig Dis Sci 2011; 56: 170- 5.

[17] Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021; 21: 426- 40.

[18] Zaura E, Nicu EA, Krom BP, et al. Acquiring and maintaining a normal oral microbiome: current perspective. Front Cell Infect Mi 2014; 4: 85.

[19] Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol 2010; 192: 5002- 17.

[20] Wade WG. The oral microbiome in health and disease. Pharmacol Res 2013; 69: 137- 43.

[21] Sedghi L, DiMassa V, Harrington A, et al. The oral microbiome: role of key organisms and complex networks in oral health and disease. Periodontol 2000 2021; 87: 107- 31.

[22] Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 2018; 16: 745- 59.

[23] Human Microbiome Project. C. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207- 14.

[24] Proctor DM, Fukuyama JA, Loomer PM, et al. A spatial gradient of bacterial diversity in the human oral cavity shaped by salivary flow. Nat Commun 2018; 9: 681.

[25] Belstrom D, Holmstrup P, Bardow A, et al. Temporal stability of the salivary microbiota in oral health. PLoS One 2016; 11: e0147472.

[26] Escapa IF, Chen T, Huang Y, et al. New insights into human nostril microbiome from the expanded human oral microbiome database (eHOMD): a resource for the microbiome of the human aerodigestive tract. mSystems 2018; 3: e00187- 18.

[27] Bamashmous S, Kotsakis GA, Kerns KA, et al. Human variation in gingival inflammation. Proc Natl Acad Sci U S A 2021; 118: e2012578118.

[28] Bik EM, Long CD, Armitage GC, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 2010; 4: 962- 74.

[29] Poole AC, Goodrich JK, Youngblut ND, et al. Human salivary amylase gene copy number impacts oral and gut microbiomes. Cell Host Microbe 2019; 25: 553- 64.e7.

[30] Gomez A, Espinoza JL, Harkins DM, et al. Host genetic control of the oral microbiome in health and disease. Cell Host Microbe 2017; 22: 269- 78.e3.

[31] Shaw L, Ribeiro ALR, Levine AP, et al. The human salivary microbiome is shaped by shared environment rather than genetics: evidence from a large family of closely related individuals. mBio 2017; 8: e01237.

[32] Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog 2010; 6: e1000713.

[33] Vila T, Sultan AS, Montelongo-Jauregui D, et al. Oral candidiasis: a disease of opportunity. J Fungi 2020; 6: 15.

[34] Sugui JA, Peterson SW, Figat A, et al. Genetic relatedness versus biological compatibility between and related species. J Clin Microbiol 2014; 52: 3707- 21.

[35] Shah AM, Mohamed H, Fazili ABA, et al. Investigating the effect of alcohol dehydrogenase gene knockout on lipid accumulation in mucor circinelloides WJ11. J Fungi (Basel) 2022; 8: 917.

[36] Folk GA, Nelson BL. Oral histoplasmosis. Head Neck Pathol 2017; 11: 513- 6.

[37] Spallone A, Schwartz IS. Emerging fungal infections. Infect Dis Clin North Am 2021; 35: 261- 77.

[38] Santos JO, Rold WH. Entamoeba gingivalis and Trichomonas tenax: protozoa parasites living in the mouth. Arch Oral Biol 2023; 147: 105631.

[39] Mallat H, Podglajen I, Lavarde V, et al. Molecular characterization of Trichomonas tenax causing pulmonary infection. J Clin Microbiol 2004; 42: 3886- 7.

[40] Benabdelkader S, Andreani J, Gillet A, et al. Specific clones of are associated with periodontitis (Publication with Expression of Concern). PLoS One 2019; 14: e0213338.

[41] Bao X, Wiehe R, Dommisch H, et al. Entamoeba gingivalis causes oral inflammation and tissue destruction. J Dent Res 2020; 99: 561- 7.

[42] Slots J. Herpesviral-bacterial synergy in the pathogenesis of human periodontitis. Curr Opin Infect Dis 2007; 20: 278- 83.

[43] Das SK, Shobha Prakash G, Gopalakrishnan S. Detection of human herpes viruses in patients with chronic and aggressive periodontitis and relationship between viruses and clinical parameters. J Oral ad MaxillofacPathol 2012; 16: 203- 9.

[44] Slots J. Human viruses in periodontitis. Periodontol 2000 2010; 53: 89- 110.

[45] Ranjith Ambili CP, Archana V, Nisha KJ, et al. Viruses: are they really culprits for periodontal disease? A critical review. J Invest Clin Dent 2013; 5: 163- 243.

[46] Hugoson A, Norderyd O. Has the prevalence of periodontitis changed during the last 30 years? J Clin Periodontol 2008; 35: 338- 45.

[47] Greenspan D, Gange SJ, Phelan JA, et al. Incidence of oral lesions in HIV-1-infected women: Reduction with HAART. J Dent Res 2004; 83: 145- 50.

[48] Saxena D, Li Y, Yang L, et al. Human microbiome and HIV/AIDS. Curr HIV/AIDS Rep 2012; 9: 44- 51.

[49] Mukherjee PK, Chandra J, Retuerto M, et al. Oral mycobiome analysis of HIV-infected patients: identification of as an antagonist of opportunistic fungi. PLoS Pathog 2014; 10: e1003996.

[50] Minot S, Bryson A, Chehoud C, et al. Rapid evolution of the human gut virome. Proc Natl Acad Sci USA 2013; 110: 12450- 5.

[51] Abeles SR, Robles-Sikisaka R, Ly M, et al. Human oral viruses are personal, persistent and gender-consistent. ISME J 2014; 8: 1753- 67.

[52] Bachrach G, Leizerovici-Zigmond M, Zlotkin A, et al. Bacteriophage isolation from human saliva. Lett Appl Microbiol 2003; 36: 50- 3.

[53] Sullivan MB, Waterbury JB, Chisholm SW. Cyanophages infecting the oceanic cyanobacterium. Nature 2003; 424: 1047- 51.

[54] Willner D, Furlan M, Schmieder R, et al. Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity. Proc Natl Acad Sci USA 2011; 108: 4547- 53.

[55] Naidu M, Robles-Sikisaka R, Abeles SR, et al. Characterization of bacteriophage communities and CRISPR profiles from dental plaque. BMC Microbiol 2014; 14: 175.

[56] Pride DT, Salzman J, Haynes M, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J 2012; 6: 915- 26.

[57] Ly M, Abeles SR, Boehm TK, et al. Altered oral viral ecology in association with periodontal disease. Mbio 2014; 5: e01133- 14.

[58] Pang X, Tang Y-J, Ren X-H, et al. Microbiota, epithelium, inflammation, and TGF-β signaling: an intricate interaction in oncogenesis. Front Microbiol 2018; 9: 1353.

[59] Sreedevi M, Ramesh A, Dwarakanath C. Periodontal status in smokers and nonsmokers: a clinical, microbiological, and histopathological study. Int J Dent 2012; 2012: 571590.

[60] Habashneh RA, Khader YS, Alhumouz MK, et al. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study. J Periodontal Res 2012; 47: 293- 8.

[61] Perricone C, Ceccarelli F, Saccucci M, et al. Porphyromonas gingivalis and rheumatoid arthritis. Curr Opin Rheumatol 2019; 31: 517- 24.

[62] Dawes C. Salivary flow patterns and the health of hard and soft oral tissues. J Am Dent Assoc 2008; 139: 18S- 24S.

[63] Liang S, Ren H, Guo H, et al. Periodontal infection with Porphyromonas gingivalis induces preterm birth and lower birth weight in rats. Mol Oral Microbiol 2018; 33: 312- 21.

[64] Lu Y, Li Z, Peng X. Regulatory effects of oral microbe on intestinal microbiota and the illness. Front Cell Infect Microbiol 2023; 13: 1093967.

[65] Kitamoto S, Nagao-Kitamoto H, Hein R, et al. The bacterial connection between the oral cavity and the gut diseases. J Dent Res 2020; 99: 1021- 9.

[66] du Teil Espina M, Giorgio G, Harmsen G, et al. Talk to your gut: the oral-gut microbiome axis and its immunomodulatory role in the etiology of rheumatoid arthritis. FEMS Microbiol Rev 2019; 43: 1- 18.

[67] Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science 2017; 358: 359- 65.

[68] Cao X. Intestinal inflammation induced by oral bacteria. Science 2017; 358: 308- 9.

[69] Inohara N. Route connection: mouth to intestine in colitis. Cell Host Microbe 2017; 22: 730- 1.

[70] Miller WD. Diseases of the human body which have been traced to the action of mouth-bacteria. The Am J Dental Sci 1891; 25: 311- 9.

[71] Pizzo G, Guiglia R, Lo Russo L, et al. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur J Intern Med 2010; 21: 496- 502.

[72] Genco RJ, Van Dyke TE. Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol 2010; 7: 479- 80.

[73] Lundberg K, Wegner N, Yucel-Lindberg T, et al. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 2010; 6: 727- 30.

[74] Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol 2011; 7: 738- 48.

[75] Offenbacher S, Jared HL, O'Reilly PG, et al. Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 1998; 3: 233- 50.

[76] Awano S, Ansai T, Takata Y, et al. Oral health and mortality risk from pneumonia in the elderly. J Dent Res 2008; 87: 334- 9.

[77] Moore WE, Holdeman LV, Smibert RM, et al. Bacteriology of severe periodontitis in young adult humans. Infect Immun 1982; 38: 1137- 48.

[78] Socransky SS. Microbiology of periodontal disease—present status and future considerations. J Periodontol 1977; 48: 497- 504.

[79] Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005; 38: 72- 122.

[80] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209- 49.

[81] Mager DL, Haffajee AD, Devlin PM, et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005; 3: 27.

[82] Man SM, Zhang Li, DayAS , et al. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn’s disease. Inflamm Bowel Dis 2010; 16: 1008- 16.

[83] Strauss J, Kaplan GG, Beck PL, et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 1978 2011; 17: 1971- 8.

[84] Schirmer M, Denson L, Vlamakis H, et al. Compositional and temporal changes in the gut microbiome of pediatric ulcerative colitis patients are linked to disease course. Cell Host Microbe 2018; 24: 600- 10.e4.

[85] Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends Endocrinol Metab 2015; 26: 315- 21.

[86] Sanz M, Del Castillo AM, Jepsen S, et al. Periodontitis and cardiovascular diseases. Consensus report. Glob Heart 2020; 15: 1.

[87] Fak F, Tremaroli V, Bergstrom G, et al. Oral microbiota in patients with atherosclerosis. Atherosclerosis 2015; 243: 573- 8.

[88] Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.J Clin Periodontol 2013; 40: S51- 69.

[89] Hashizume-Takizawa T, Yamaguchi Y, Kobayashi R, et al. Oral challenge with Streptococcus sanguinis induces aortic inflammation and accelerates atherosclerosis in spontaneously hyperlipidemic mice. Biochem Biophys Res Commun 2019; 520: 507- 13.

[90] Sparks JA. Rheumatoid arthritis. Ann Intern Med 2019; 170: ITC1- ITC16.

[91] Del Puente A, Knowler WC, Pettitt DJ, et al. High incidence and prevalence of rheumatoid arthritis in Pima Indians. Am J Epidemiol 1989; 129: 1170- 8.

[92] Beasley RP, Bennett PH, Lin CC. Low prevalence of rheumatoid arthritis in Chinese. Prevalence survey in a rural community. J Rheumatol Suppl 1983; 10: 11- 5.

[93] Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010; 37: 1105- 12.

[94] Brewer RC, Lanz TV, Hale CR, et al. Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis. Sci Transl Med 2023; 15: eabq8476.

[95] Zhao Y, Li Z, Su L, et al. Characterization and regulation of osteoclast precursors following chronic Porphyromonas gingivalis infection. J Leukoc Biol 2020; 108: 1037- 50.

[96] Farquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol 2012; 5: 112- 20.

[97] Mendz GL, Kaakoush NO, Quinlivan JA. Bacterial aetiological agents of intra-amniotic infections and preterm birth in pregnant women. Front Cell Infect Microbiol 2013; 3: 58.

[98] Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996; 67: 1103- 13.

[99] Fardini Y, Chung P, Dumm R, et al. Transmission of diverse oral bacteria to murine placenta: evidence for the oral microbiome as a potential source of intrauterine infection. Infect Immun 2010; 78: 1789- 96.

[100] Ao M, Miyauchi M, Furusho H, et al. Dental infection of Porphyromonas gingivalis induces preterm birth in mice. PLoS One 2015; 10: e0137249.

[101] Slade GD, Ghezzi EM, Heiss G, et al. Relationship between periodontal disease and C-reactive protein among adults in the atherosclerosis risk in communities study. Arch Intern Med 2003; 163: 1172- 9.

[102] Choi S, Kim K, Chang J, et al. Association of chronic periodontitis on Alzheimer’s disease or vascular dementia. J Am Geriatr Soc 2019; 67: 1234- 9.

[103] Chen C-K, Wu Y-T, Chang Y-C. Association between chronic periodontitis and the risk of Alzheimer’s disease: a retrospective, populationbased, matched-cohort study. Alzheimers Res Ther 2017; 9: 56.

[104] Miklossy J. Alzheimers-disease—a spirochetosis. Neuroreport 1993; 4: 841- 8.

[105] Poole S, Singhrao SK, Kesavalu L, et al. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis 2013; 36: 665- 77.

[106] Díaz-Zúñiga J, More J, Melgar-Rodríguez S, et al. Alzheimer’s disease-like pathology triggered by Porphyromonas gingivalis in wild type rats is serotype dependent. Front Immunol 2020; 11: 588036.

[107] Ding Y, Ren J, Yu H, et al. Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun Ageing 2018; 15: 6.

[108] Gu Y, Wu Z, Zeng F, et al. Systemic exposure to lipopolysaccharide from Porphyromonas gingivalis induces bone loss-correlated Alzheimer’s disease-like pathologies in middle-aged mice. J Alzheimers Dis 2020; 78: 61- 74.

[109] Hayashi K, Hasegawa Y, Takemoto Y, et al. Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer’s disease. Exp Gerontol 2019; 120: 1- 5.

[110] Liu J, Wang Y, Guo J, et al. Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Aβ level in Porphyromonas gingivalis-infected mice. Aging (Albany) 2020; 12: 10117- 28.

[111] Wu Z, Ni J, Liu Y, et al. Cathepsin B plays a critical role in inducing Alzheimer’s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav Immun 2017; 65: 350- 61.

[112] Nie R, Wu Z, Ni J, et al. Porphyromonas gingivalis infection induces amyloid-β accumulation in monocytes/macrophages. J Alzheimers Dis 2019; 72: 479- 94.

[113] Hu Y, Li H, Zhang J, et al. Periodontitis induced by P. gingivalis-LPS Is associated with neuroinflammation and learning and memory impairment in Sprague-Dawley rats. Front Neurosci 2020; 14: 658.

[114] Bahar B, Kanagasingam S, Tambuwala MM, et al. Porphyromonas gingivalis (W83) infection induces Alzheimer’s disease-like pathophysiology in obese and diabetic mice. J Alzheimers Dis 2021; 82: 1259- 75.

[115] Tang Z, Liang D, Cheng M, et al. Effects of Porphyromonas gingivalis and its underlying mechanisms on Alzheimer-like tau hyperphosphorylation in Sprague-Dawley rats. J Mol Neurosci 2021; 71: 89- 100.

[116] Ilievski V, Zuchowska PK, Green SJ, et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS One 2018; 13: e0204941.

[117] Dickstein JB, Moldofsky H, Hay JB. Brain-blood permeability: TNF-alpha promotes escape of protein tracer from CSF to blood. Am J Physiol Regul Integr Comp Physiol 2000; 279: R148- 151.

[118] Crielaard W, Zaura E, Schuller AA, et al. Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med Genomics 2011; 4: 13.

[119] Percival RS, Challacombe SJ, Marsh PD. Age-related microbiological changes in the salivary and plaque microflora of healthy-adults. J Med Microbiol 1991; 35: 5- 11.

[120] Preza D, Olsen I, Willumsen T, et al. Microarray analysis of the microflora of root caries in elderly. Eur J Clin Microbiol Infect Dis 2009; 28: 509- 17.

[121] Liu SL, Wang YH, Zhao L, et al. Microbiome succession with increasing age in three oral sites. Aging (Milano) 2020; 12: 7874- 907.

[122] Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107: 11971- 5.

[123] Yassour M, Vatanen T, Siljander H, et al; on behalf of the DIABIMMUNE Study Group. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 2016; 8: 343ra81.

[124] Martino C, Dilmore AH, Burcham ZM, et al. Microbiota succession throughout life from the cradle to the grave. Nat Rev Microbiol 2022; 20: 707- 20.

[125] Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat 2019; 18: 1533033819867354.

[126] Huang C, Shi G. Smoking and microbiome in oral, airway, gut and some systemic diseases. J Transl Med 2019; 17: 225.

[127] Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5: e177.

[128] Walford RL. The immunologic theory of aging. Gerontologist 1964; 4: 195- 7.

[129] Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244- 54.

[130] Shi B, Chang M, Martin J, et al. Dynamic changes in the subgingival microbiome and their potential for diagnosis and prognosis of periodontitis. mBio 2015; 6: e01926- 14.

[131] How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol 2016; 7: 14.

[132] Moutsopoulos NM, Madianos PN. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann N Y Acad Sci 2006; 1088: 251- 64.

[133] Scannapieco FA, Cantos A. Oral inflammation and infection, and chronic medical diseases: implications for the elderly. Periodontol 2000 2016; 72: 153- 75.

[134] Mejare I, Axelsson S, Dahlén G, et al. Caries risk assessment. A systematic review. Acta Odontol Scand 2014; 72: 81- 91.

[135] Teng F, Yang F, Huang S, et al. Prediction of early childhood caries via spatial-temporal variations of oral microbiota. Cell Host Microbe 2015; 18: 296- 306.

[136] Flemer B, Warren RD, Barrett MP, et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 2018; 67: 1454- 63.

[137] Bago I, Bago J, Plečko V, et al. The effectiveness of systemic eradication therapy against oral Helicobacter pylori. J Oral Pathol Med 2011; 40: 428- 32.

[138] Song HY, Li Y. Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori? World J Gastroenterol 2013; 19: 6645- 50.

[139] Bouziane A, Ahid S, Abouqal R, et al. Effect of periodontal therapy on prevention of gastric Helicobacter pylori recurrence: a systematic review and meta-analysis. J Clin Periodontol 2012; 39: 1166- 73.

[140] Dassi E, Ferretti P, Covello G, et al; HTM-CMB-2015. The short-term impact of probiotic consumption on the oral cavity microbiome. Sci Rep 2018; 8: 10476.

[141] Devine DA, Marsh PD, Meade J. Modulation of host responses by oral commensal bacteria. J Oral Microbiol 2015; 7: 26941.

[142] López-López A, Camelo-Castillo A, Ferrer MD, et al. Health-associated niche inhabitants as oral probiotics: the case of Streptococcus dentisani. Front Microbiol 2017; 8: 379.

[143] Huang X, Palmer SR, Ahn S-J, et al. A highly arginolytic streptococcus species that potently antagonizes streptococcus mutans. Appl Environ Microbiol 2016; 82: 2187- 201.

[144] Dominy SS, Lynch C, Ermini F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 2019; 5: eaau3333.

[145] Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015; 21: 895- 905.

RIGHTS & PERMISSIONS

The Author(s). Published by Oxford University Press on behalf of Higher Education Press.